Atlas Trials

Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

Clinical trial NCT01757171 · COMPLETED

Trial details

NCT number
NCT01757171
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric AdenocarcinomaGastroesophageal AdenocarcinomaDistal Esophageal Adenocarcinoma
Start date
2012-12-01
Primary completion
2016-07-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.